Skip to main content
. 2019 Oct 31;4(5):e001825. doi: 10.1136/bmjgh-2019-001825

Figure 3.

Figure 3

Cost-effectiveness of childhood cancer treatments*. ALL, acute lymphoblastic leukaemia; BL, Burkitt lymphoma; DALY, disability-adjusted life year; GDP, gross domestic product. *Only includes studies with extracted or calculated cost per DALY averted that were ranked as ‘Comprehensive’ or ‘Medium’ for number of inputs included in cost analysis.